Primary Patient-Derived Cancer Cells and Their Potential for Personalized Cancer Patient Care

Primary Patient-Derived Cancer Cells and Their Potential for Personalized Cancer Patient Care

Personalized cancer therapy is based on a patient’s tumor lineage, histopathology, expression analyses, and/or tumor DNA or RNA analysis. Here, we aim to develop an in vitro functional assay of a patient’s living cancer cells that could complement these approaches. We present methods for developing...

Full description

Bibliographic Details
Main Authors: David P. Kodack, Anna F. Farago, Anahita Dastur, Matthew A. Held, Leila Dardaei, Luc Friboulet, Friedrich von Flotow, Leah J. Damon, Dana Lee, Melissa Parks, Richard Dicecca, Max Greenberg, Krystina E. Kattermann, Amanda K. Riley, Florian J. Fintelmann, Coleen Rizzo, Zofia Piotrowska, Alice T. Shaw, Justin F. Gainor, Lecia V. Sequist, Matthew J. Niederst, Jeffrey A. Engelman, Cyril H. Benes
Format: Article
Language:English
Published: Elsevier 2017-12-01
Series:Cell Reports
Subjects:
patient-derived cancer cells
NSCLC
personalized medicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124717317035

Similar Items

Similar Items